Evidence map›Paper›PMID 24086495›Full record

ArticlePloS one2013

Extracellular signal-regulated kinase 1/2 signaling pathway is required for endometrial decidualization in mice and human.

Chae Hyun Lee, Tae Hoon Kim, Jae Hee Lee, Seo Jin Oh, Jung-Yoon Yoo, Hyo Suk Kwon, Young Im Kim, Susan D Ferguson, Ji Yeon Ahn, Bon Jeong Ku and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The landscape ofBiomolecules & biomedicine · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Chae Hyun LeeDepartment of Obstetrics, Gynecology & Reproductive Biology, Michigan State University College of Human Medicine, Grand Rapids, Michigan, United States of America ; Department of Agricultural Biotechnology, Seoul National University, Seoul, South Korea.
Tae Hoon Kim
Jae Hee Lee
Seo Jin Oh
Jung-Yoon Yoo
Hyo Suk Kwon
Young Im Kim
Susan D Ferguson
Ji Yeon Ahn
Bon Jeong Ku
Asgerally T Fazleabas
Jeong Mook Lim
Jae-Wook Jeong
Michigan State University · USSeoul National University · KRChungnam National University · KRGrand Rapids Community College · USMichigan United · USSeoul National University Hospital · KR

Funding

Targeting the PI3K Signaling Pathway in Endometrial CarcinomaP50CA098258 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BODURKA, DIANE · 2003 to 2020
$32.0M
Tissue Procurement and Cell CultureU54HD040093 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FAZLEABAS, ASGERALLY T. · 2002 to 2011
$13.1M
Steroid Hormone Regulation of Uterine Function and DysfunctionR01HD057873 · NICHD · MICHIGAN STATE UNIVERSITY · PI JEONG, JAE-WOOK · 2008 to 2012
$1.3M
NICHD NIH HHS R01 HD057873NICHD NIH HHS R01HD057873NICHD NIH HHS U54 HD040093NICHD NIH HHS U54HD40093
6 · The paper itself

Abstract

Decidualization is a crucial change required for successful embryo implantation and the maintenance of pregnancy. During this process, endometrial stromal cells differentiate into decidual cells in response to the ovarian steroid hormones of early pregnancy. Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) are known to regulate cell proliferation and apoptosis in multiple cell types, including uterine endometrial cells. Aberrant activation of ERK1/2 has recently been implicated in the pathological processes of endometriosis and endometrial cancer. However, the function of ERK1/2 signaling during implantation and decidualization is still unknown. To determine the role and regulation of ERK1/2 signaling during implantation and decidualization, we examine ERK1/2 signaling in the mouse uterus during early pregnancy using immunostaining and qPCR. Interestingly, levels of phospho-ERK1/2 were highest within decidual cells located at the implantation sites. Expression levels of ERK1/2 target genes were also significantly higher at implantation sites, when compared to either inter-implantation sites. To determine if ERK1/2 signaling is also important during human endometrial decidualization, we examined levels of phospho-ERK1/2 in cultured human endometrial stromal cells during in vitro decidualization. Following treatment with a well-established decidualization-inducing steroidogenic cocktail, levels of phospho-ERK1/2 were markedly increased. Treatment with the ERK1/2 inhibitor, U0126, significantly decreased the expression of the known decidualization marker genes, IGFBP1 and PRL as well as inhibited the induction of known ERK1/2 target genes; FOS, MSK1, STAT1, and STAT3. Interestingly, the phosphorylation level of CCAAT/ enhancer binding protein β (C/EBPβ), a protein previously shown to be critical for decidualization, was significantly reduced in this model. These results suggest that ERK1/2 signaling is required for successful decidualization in mice as well as human endometrial stromal cells and implicates C/EBPβ as a downstream target of ERK1/2.

Indexed as

Analysis of VarianceAnimalsBlotting, WesternButadienesCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding ProteinsCell DifferentiationDeciduaEmbryo ImplantationFemaleFluorescent Antibody TechniqueGene Expression RegulationHumansImmunohistochemistryInsulin-Like Growth Factor Binding Protein 1In Vitro TechniquesButadienesCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding ProteinsCEBPB protein, humanIGFBP1 protein, humanInsulin-Like Growth Factor Binding Protein 1NitrilesProlactinU 0126

Identifiers

PMID24086495
PMCPMC3782496
OpenAlexW2049406959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.